3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
3
Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Nasopharyngeal Carcinoma
1
Melanoma
1
Locally Advanced Rectal Adenocarcinoma
1
Locally Advanced Cervical Carcinoma
1
Liver Neoplasms
1
Liver Diseases
1
Head and Neck Neoplasms
1
Gastric Cancer With Liver Metastases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Breast Neoplasms, Male
1
Adenocarcinoma
1
Interventions
pembrolizumab
29
Paclitaxel
13
Carboplatin
11
Cisplatin
10
Pemetrexed
6
lenvatinib
5
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
4
Capecitabine
4
Albumin-Bound Paclitaxel
4
patritumab deruxtecan
3
olaparib
3
Leucovorin
3
Acetaminophen
3
130-nm albumin-bound paclitaxel
3
belzutifan
2
Levoleucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Etoposide
2
Docetaxel
2
Dexamethasone
2
Cetuximab
2
Bevacizumab
2
Axitinib
2
zanidatamab
1
trifluridine tipiracil drug combination
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Immunotherapy
×
30 days
×
Clear all
No trials found.